The partial reduction of circulating leptin levels through genetic and antibody-blocking approaches improves leptin resistance, thereby decreasing food intake and increasing energy expenditure in obese mice40,41, providing insights into the treatment of obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.